Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin’s lymphoma: Results of the prospective multicenter H96 trial by the GELA/SFGM study group - Morschhauser, F; Brice, P; Fermé, C (J Clin Oncol, 2008)
et al.